DANIEL DRAKE CENTER FOR POST-ACUTE C — History
CCN 362004 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$39M
Latest Revenue (FY2022)
-4.2%
Revenue CAGR (3yr)
-51.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $42M | $40M | $39M | -3.3% | -4.2% |
| Operating Expenses | $66M | $73M | $59M | -18.7% | -5.2% |
| Operating Margin | -54.6% | -80.3% | -51.5% | +35.9% | +0.0% |
| Net Income | $-23M | $-32M | $-20M | +38.0% | +0.0% |
| Licensed Beds | 82 | 82 | 82 | +0.0% | +0.0% |
| Total Patient Days | 12,104 | 10,155 | 9,226 | -9.1% | -12.7% |
| Medicare Day % | 27% | 18% | 23% | +29.8% | -8.7% |
| Medicaid Day % | 10% | 5% | 7% | +27.2% | -19.0% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: -8.3% ($42M → $39M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-4.2%
This Hospital
+7.6%
State Avg
Latest Margin
-51.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $37M | -49.9% |
| FY2024 (proj) | $35M | -48.4% |
| FY2025 (proj) | $34M | -46.8% |